COMMUNIQUÉS West-GlobeNewswire

InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
22/09/2025
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the [...]
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
22/09/2025
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG105 1 , a pre-clinical investigational novel compound with broad potential to treat brain health diseases, [...]
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
22/09/2025
Joy and Impact Unleashed as Comedy Tour Funds Critical Relief for Those in Need TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Humanitarian aid nonprofit, Human Appeal Canada , is kicking off their second annual comedy [...]
Guerbet : Evolution de la Direction Générale
22/09/2025
Evolution de la Direction Générale Villepinte, le 22 septembre 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination de [...]
Guerbet : Change in General Management
22/09/2025
Change in General Management Villepinte France, September 22nd, 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Jérôme [...]
New mobile units to drive early breast cancer detection in Alberta
22/09/2025
Alberta Cancer Foundation and Primary Care Alberta bring life-saving breast cancer screening to women in rural and remote communities EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is now [...]
IBA SA – NOTIFICATION TRANSPARENCE
22/09/2025
(Article 14, alinéa 1 er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve (Belgique), le 22 septembre 2025, 18h00 Résumé de la notification IBA (Ion Beam Applications S.A [...]
IBA – Transparency Notification
22/09/2025
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve (Belgium), 22 September 2025, 06:00 PM Summary of the notification IBA (Ion Beam Applications S.A - EURONEXT - [...]
Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS
22/09/2025
MIDDLETOWN, Conn., Sept. 22, 2025 (GLOBE NEWSWIRE) -- During September’s PCOS Awareness Month, Fairhaven Health is drawing attention to the role targeted nutrition can play in supporting women affected by polycystic [...]
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
22/09/2025
EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its new Life Sciences [...]
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Lead Strategic Partnerships; Appoints Veteran Costco Buyer to Board of Directors
22/09/2025
Board member Scott Woodburn transitions to Head of Strategic Partnerships to accelerate FOCUSfactor Energy Drink expansion Former Costco Buyer Teresa Thompson brings nearly 40 years of retail expertise in vitamins and [...]
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
22/09/2025
GW Cancer Center to initiate Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in HR+/HER2-neg breast cancer patients Second investigator-initiated trial to [...]
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
22/09/2025
~Patient Recruitment Closed~ LA JOLLA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock [...]
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
22/09/2025
SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has [...]
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
22/09/2025
Presentation Highlighted Data Supporting Clinical Benefit of GTx-104 Compared to Orally Administered Nimodipine in the Treatment of aneurysmal Subarachnoid Hemorrhage (aSAH) PRINCETON, N.J., Sept. 22, 2025 (GLOBE [...]
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
22/09/2025
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Connect , a premier nonprofit organization in San Diego’s innovation ecosystem, dedicated to supporting entrepreneurs and cultivating thriving life science and technology [...]
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
22/09/2025
FDA grants Priority Review to idebenone for Leber Hereditary Optic Neuropathy (LHON), a disease for which there are no existing approved treatments in the U.S.; action date of February 28, 2026 People living with LHON [...]
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
22/09/2025
Study led by CureShank Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system MADRID and CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. ( [...]
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
22/09/2025
ROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga™ Plus handheld vagus nerve [...]

Pages